Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Pratik S. Multani, MD, MS
ORIC Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
42 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chris O'Brien Lifehouse
Camperdown, Australia
Recruiting - Peter Maccallum Cancer Centre
Melbourne, Australia
Recruiting - One Clinical Research, Hollywood Medical Centre
Nedlands, Australia
Recruiting - Sydney Adventist Health
Sydney, Australia
Recruiting
- Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Recruiting
- the Chinese University of Hong Kong
Shatin, Hong Kong
Recruiting
- Sultan Ahmad Shah Medical Centre at International Islamic University Malaysia (iium)
Kuantan, Pahang, Malaysia
Recruiting - Pulau Pinang Hospital
George Town, Pulau Pinang, Malaysia
Recruiting - Sarawak General Hospital (sgh)
Kuching, Sarawak, Malaysia
Recruiting - Hospital Kuala Lumpur
Kuala Lumpur, Malaysia
Recruiting - University of Malaya Medical Center (ummc)
Kuala Lumpur, Malaysia
Recruiting
- Medical University of Gdańsk
Gdansk, Poland
Recruiting
- Chungbuk University Hospital
Cheongju-si, South Korea
Recruiting - National Cancer Center
Goyang-si, South Korea
Recruiting - Catholic University of Korea, St, Vincent Hospital
Gyeonggi-do, South Korea
Recruiting - Gachon University Hospital
Incheon, South Korea
Recruiting - Seoul National Bundang Hospital
Seongnam-si, South Korea
Recruiting - Asan Medical Center
Seoul, South Korea
Recruiting - Samsung Medical Center
Seoul, South Korea
Recruiting - Severance Hospital, Yonsei University Health System
Seoul, South Korea
Recruiting
- Next Oncology - Barcelona
Barcelona, Spain
Recruiting - Vall D'Hebron Institute of Oncology (vhio)
Barcelona, Spain
Recruiting - Next Oncology - Madrid
Madrid, Spain
Recruiting
- National Taiwan University Hospital
Taipei, Taiwan
Recruiting
- the Christie Nhs Foundation Trust
Manchester, England, United Kingdom
Recruiting
- City of Hope
Duarte, California, United States
Recruiting - City of Hope
Huntington Beach, California, United States
Recruiting - City of Hope
Irvine, California, United States
Recruiting - City of Hope
Long Beach, California, United States
Recruiting - University of California, San Francisco
San Francisco, California, United States
Recruiting - Yale Cancer Center
New Haven, Connecticut, United States
Recruiting - Georgetown University
Washington D.C., District of Columbia, United States
Recruiting - Mayo Clinic
Jacksonville, Florida, United States
Recruiting - Moffitt Cancer Center
Tampa, Florida, United States
Recruiting - Northwestern University
Chicago, Illinois, United States
Recruiting - Dana Farber Cancer Institute
Boston, Massachusetts, United States
Recruiting - Mayo Clinic
Rochester, Minnesota, United States
Recruiting - Nyu Langone Health Perlmutter Cancer Center
New York, New York, United States
Recruiting - Duke Cancer Institute
Durham, North Carolina, United States
Recruiting - University of Pennsylvania
Philadelphia, Pennsylvania, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Mar 2022
- Primary completion
- 30 Sept 2026
- Completion
- 30 Sept 2027
- Last update posted
- 5 Aug 2025
- Registered enrollment
- 350
- Registry id
- NCT05315700
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.